2025. PCSK9 Targeted Therapy to Lower Cholesterol and Reduce Cardiovascular Events. Actualité Cardiologique au Canada. 1, 1 (mars 2025), 20–25. DOI:https://doi.org/10.58931/cct.2025.114.